BARDA T2 Biosystems Exercises BARDA Contract Option Valued at $4.4M The funds will advance T2's next-generation instrument and also support clinical trials of panels for biothreats and antimicrobial resistance. Visby Medical Executes $25.5M BARDA Contract to Develop At-Home Flu, COVID-19 PCR Test The firm will use the funding to obtain FDA clearance for a combo test that will be offered directly to consumers by prescription. Detect Nabs $22.9M BARDA Award to Develop Rapid Molecular COVID-19/Flu Test The test includes Detect's reusable base station, a single-use cartridge, and a mobile app to detect SARS-CoV-2 and influenza A/B in less than 30 minutes. Becton Dickinson, BARDA Ink $40.3M Contract for Five Combo Assays The tests could be used to make treatment and management decisions, and inform on epidemiologic trends or new and emerging viruses. BARDA Exercises $6.4M Option on T2 Biosystems Contract The funding supports development of antimicrobial resistance, biothreat agent, and sepsis pathogen panels, as well as a next-gen instrument. Jul 30, 2021 Cepheid Gets $28M From BARDA for SARS-CoV-2 Tests May 6, 2021 T2 Biosystems Q1 Revenues Nearly Triple Apr 26, 2021 TGen, Jumpcode Genomics Marrying NGS, CRISPR to Build a Better COVID-19 Test Premium Feb 12, 2021 Federal Agencies Collaborate to Solicit Proposals for SARS-CoV-2 Testing Supply Chain Scale-up Feb 11, 2021 Cue Health Ramping Up COVID-19 Test Production Following Positive Mayo Clinic Study, DoD Funding Premium Feb 2, 2021 Visby Medical Wins $12.3M BARDA Contract for Coronavirus, Flu Combo Test Jan 13, 2021 BARDA Provides Additional Funding to DiaSorin Molecular for COVID-19 Tests Nov 18, 2020 FDA Grants Emergency Use Authorization to First At-Home COVID-19 Test From Lucira Health Nov 6, 2020 Mesa Biotech Awarded $13M in BARDA Funding for Coronavirus, Flu Combo Test Nov 2, 2020 Hologic Wins $119M Contract From US Government to Expand COVID-19 Test Capacity Oct 6, 2020 RAD-X Awards Six Phase 2 Contracts for COVID-19 Testing Sep 30, 2020 BARDA Exercises $10.5M Option on T2 Bio Contract Sep 24, 2020 BARDA Awards $5.4M to Luminex for Expanded Respiratory Panel With Coronavirus Target Sep 14, 2020 GenMark Diagnostics Receives CE Mark for Respiratory Panel Including SARS-CoV-2, Flu Sep 8, 2020 As Flu Season Nears, Dx Companies Shift Attention to Multiplex Tests for SARS-CoV-2, Influenza Premium Sep 1, 2020 Immunexpress, Biocartis to Roll Out Sepsis Test in Europe Ahead of Planned US Launch Premium Aug 5, 2020 Visby Medical Gonorrhea Test Wins $19M AMR Diagnostic Competition Jun 16, 2020 Immunexpress Nabs $599K BARDA Contract to Develop Sepsis Test for Coronavirus Patient Triage May 5, 2020 Tangen Biosciences Receives Additional $3.3M From BARDA May 4, 2020 Hologic Awarded $13M from BARDA to Develop Second Coronavirus Assay Load More Breaking News Qiagen Gets CE Mark for Therascreen EGFR Plus RGQ Kit for Non-Small Cell Lung Cancer New CRISPR Approach Enables Gene Editing in Cockroaches, Potentially Many Insect Species Delfi Diagnostics, Memorial Sloan Kettering Partner to Advance Cancer Screening Technology Mirvie Raises $60M in Series B Funding Interpace Biosciences Posts 6 Percent Revenue Increase in Q1 Ginkgo Bioworks Q1 Revenues More Than Triple The Scan Booster for Kids The US Food and Drug Administration has authorized a booster dose of Pfizer-BioNTech's SARS-CoV-2 vaccine for 5-to-11-year olds, the Washington Post reports. Novavax Anticipates Authorization Novavax expects to receive US Food and Drug Administration authorization for vaccine soon, according to CNBC. Some Old Microbes Indeed Vice reports that researchers may have uncovered 830-million-year-old microbes. PNAS Papers on Meiotic Crossover, RNA Targeting, SNAT7 mTORC1 Regulation In PNAS this week: meiotic crossover formation in C. elegans, approach to identify small molecules affecting RNA activity, and more.